Login to Your Account

Other News To Note

Thursday, September 5, 2013
Globeimmune Inc., of Louisville, Colo., said it was awarded a research project grant of $4 million from the National Institute of Allergy and Infectious Diseases to support the development of Tarmogen immunotherapy products to treat and prevent tuberculosis infection.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription